AMCP CEO Blog: Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.
Centers for Medicare and Medicaid Services (CMS) is issuing this memorandum to provide clarifying guidance to Medicare Part D plan sponsors concerning the Part D program’s any willing pharmacy (AWP) requirement.
On August 22, 2014, the DEA issued a final rule (79 FR 49661) in which they rescheduled hydrocodone combination products (HCPs) from schedule III to schedule II of the Controlled Substances Act as of October 6, 2014.
